These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 30027448

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Sebaceous gland carcinoma of the ocular adnexa - variability in clinical and histological appearance with analysis of immunohistochemical staining patterns.
    Schmitz EJ, Herwig-Carl MC, Holz FG, Loeffler KU.
    Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2277-2285. PubMed ID: 28741159
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. ZEB2/SIP1 as novel prognostic indicator in eyelid sebaceous gland carcinoma.
    Bhardwaj M, Sen S, Sharma A, Kashyap S, Chosdol K, Pushker N, Bajaj MS, Bakhshi S.
    Hum Pathol; 2015 Oct; 46(10):1437-42. PubMed ID: 26220160
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cancer Stem Cell Markers in Eyelid Sebaceous Gland Carcinoma: High Expression of ALDH1, CD133, and ABCG2 Correlates With Poor Prognosis.
    Kim N, Choung HK, Lee MJ, Khwarg SI, Kim JE.
    Invest Ophthalmol Vis Sci; 2015 Feb 24; 56(3):1813-9. PubMed ID: 25711631
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Retinoid receptor subtypes in sebaceous cell carcinoma of the eyelid.
    Chakravarti N, Saadati HG, El-Naggar AK, Lotan R, Diba RE, Esmaeli B.
    Ophthalmic Plast Reconstr Surg; 2005 Jul 24; 21(4):292-7. PubMed ID: 16052143
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Correlation of the expression of telomerase RNA with risk factors for recurrence of sebaceous gland carcinoma.
    Li B, Li N, Cheng G, Sun X, Xu X, Shi J, Li L, Chen C.
    Graefes Arch Clin Exp Ophthalmol; 2006 Apr 24; 244(4):480-4. PubMed ID: 16133023
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Eyelid sebaceous gland carcinoma, validation of AJCC 8th edition T staging- a retrospective study from North India.
    Sen S, Bhardwaj M, Jayaraj P, Bakhshi S, Pushker N, Kashyap S, Bajaj MS, Khandpur S.
    Acta Ophthalmol; 2023 Feb 24; 101(1):49-56. PubMed ID: 35751173
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.